OPTN (Option Therapeutics) Total Operating Expense: $0.45 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Option Therapeutics Total Operating Expense?

Option Therapeutics OPTN Total Operating Expense is $0.45 Mil as of Dec. 2025.

Option Therapeutics's Total Operating Expense for the three months ended in Dec. 2025 was $0.19 Mil. Option Therapeutics's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was $0.45 Mil.

Option Therapeutics Total Operating Expense Related Terms

Option Therapeutics Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Option Therapeutics's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Option Therapeutics Total Operating Expense Chart

Option Therapeutics Annual Data
Trend Jun24 Jun25
Total Operating Expense
1.94 1.22

Option Therapeutics Quarterly Data
Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Total Operating Expense Get a 7-Day Free Trial 0.11 0.29 0.00 0.26 0.19

Option Therapeutics Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $0.45 Mil mean?
Option Therapeutics (OPTN) has a Total Operating Expense of $0.45 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Option Therapeutics and its competitors.
Is Option Therapeutics' Total Operating Expense too high?
Option Therapeutics' current Total Operating Expense is $0.45 Mil.
How does Option Therapeutics' Total Operating Expense compare to ?
Option Therapeutics' Total Operating Expense of $0.45 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Option Therapeutics and its competitors. Option Therapeutics's current Total Operating Expense is $0.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Option Therapeutics stock overvalued right now?
Option Therapeutics (OPTN) has a current Total Operating Expense of $0.45 Mil. The current Total Operating Expense is $0.45 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Option Therapeutics (OPTN), the current Total Operating Expense is $0.45 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Option Therapeutics Business Description

Comparable Companies
Address 680 West Nye Lane, Suite 201, Carson, NV, USA, 89703
Option Therapeutics Inc is a clinical-stage company developing inventive drug therapies to treat debilitating and life-threatening liver disease through its investigational drug candidate BIV201 (continuous infusion terlipressin). BIV201 is administered as a patent-pending liquid formulation of terlipressin with patents issued, to date, in the U.S., China, Japan, Chile, and India.